Novel Therapies in IgA Nephropathy Bring New Options, and New Questions

By News Health
1 hour Ago

(MedPage Today) — Clinicians face exciting new options in immunoglobulin A (IgA) nephropathy, with recent accelerated FDA approvals and positive data presented on agents targeting B-cell activating factor (BAFF) and a proliferation-inducing ligand…

Source link : https://www.medpagetoday.com/meetingcoverage/kidneyweekvideopearls/118987

Author :

Publish date : 2025-12-12 17:20:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Mounjaro Cleared for Type 2 Diabetes in EU Children

Pre-Op MRI Shows 'No Clinical Benefit' in Early Breast Cancer

New Biologic Cleared for Severe Asthma and Nasal Polyps

Taylor Swift Fans' 'Joy Blackouts' Are Completely Normal

Amid Uproar, Lawmakers Push to Add Nursing to 'Professional' Programs List

Mars may once have had a much larger moon